| Literature DB >> 6134834 |
J J Baldwin, G H Denny, R Hirschmann, M B Freedman, G S Ponticello, D M Gross, C S Sweet.
Abstract
A series of 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazoles is described. The compounds were investigated in vitro for beta-adrenoceptor antagonism, and several examples were found to be selective for the beta 1-adrenoceptor. The structure--activity relationship exhibited by this series of compounds is discussed. (S)-2-[p-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]phenyl]-4-(2 -thienyl)imidazole [(S)-13] was over 100 times more selective than atenolol for the beta 1-adrenergic receptor and has been selected for in-depth studies.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6134834 DOI: 10.1021/jm00361a004
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446